Ken Griffin HALOZYME THERAPEUTICS INC Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
Number of Shares
10,094,000
Previous 33,209,000
69.6%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%